Responses
Miscellaneous
2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement initiative
Compose a Response to This Article
Other responses
No responses have been published for this article.